| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |